(-)-Camphor

(-)-Camphor

SCHEMBL1701376

CC1(C)[C@H]2CC[C@]1(C)C(=O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
KMT2A Q03164 4/20 1.00
MEN1 O00255 3/20 1.00
MAPT P10636 2/20 1.00
LMNA P02545 1/20 1.00
L3MBTL1 Q9Y468 1/20 0.52
PTPN1 P18031 1/20 0.41
F2 P00734 2/20 0.41
PRSS1 P07477 2/20 0.41
PRSS2 P07478 2/20 0.41
PRSS3 P35030 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Camphor SCHEMBL31059217 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL16068 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL1151878 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL1712401 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL16582770 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL13248606 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL15542393 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL2037672 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL285280 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL29673264 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
CN-120044148-A Finger print of qi-regulating and blood-activating preparation and establishing method 贵州益佰制药股份有限公司 2025-05-27 CN claimed
CN-119096988-A Attractant for termites and screening method thereof 湖南通达生物科技有限公司 2024-12-10 CN claimed
US-20240374492-A1 A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION ISP INVESTMENTS LLC (US) 2024-11-14 US claimed
WO-2024213536-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2024-10-17 WO claimed
CN-118549575-A Detection method of fingerprint spectrum of chemical components in nasosinusitis oral liquid volatile oil, establishment method of fingerprint spectrum and application of fingerprint spectrum 成都华神科技集团股份有限公司 2024-08-27 CN claimed
US-11993576-B2 N-benzyl-N-arylsulfonamide derivative and preparation and use thereof HANGZHOU YIRUI PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) 2024-05-28 US claimed
US-20240050393-A1 COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS GILVERDI - HEALTH AND BEAUTY LTD (IL) 2024-02-15 US claimed
EP-4319559-A1 METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS Eastman Chemical Company (US) 2024-02-14 EP claimed
CN-117007733-B High performance liquid chromatography determination method for five components in sweet wormwood herb paste 威胜生物医药(苏州)股份有限公司 2024-01-12 CN claimed
CN-111748484-A Pseudomonas resinovorans, borneol dehydrogenase, mixture containing pseudomonas oleovorans and borneol dehydrogenase and application of mixture 慈济学校财团法人慈济大学 2020-10-09 CN claimed
US-20190218476-A1 FRAGRANCE COMPOSITIONS GIVAUDAN SA (CH) 2019-07-18 US claimed
CN-106117186-A A kind of voriconazole and the preparation method of intermediate thereof 重庆莱美隆宇药业有限公司 2016-11-16 CN claimed
CN-105407718-A Coated particles and compositions comprising the same VYOME BIOSCIENCES 2016-03-16 CN claimed
US-20100047185-A1 ACTVIE SUBSTANCE COMBINATION ISDIN S.A. (ES) 2010-02-25 US claimed
CN-1575658-A Plant Source non-public hazard biological insect repellant and preparing process WANG LIHUA (CN) 2005-02-09 CN claimed
EP-1490018-A2 SUNSCREEN COMPOSITIONS AND METHODS AND MATERIALS FOR PRODUCING THE SAME The C.P. Hall Company (US) 2004-12-29 EP claimed
WO-2003075877-A2 SUNSCREEN COMPOSITIONS AS WELL AS METHODS AND MATERIALS FOR PRODUCING THE SAME, WHEREIN THE PHOTODECAY RATE OF THE FILTER SYSTEM IS REDUCED BY CONTROLLING THE POLARITY OF THE SOLVENT SYSTEM THE C.P. HALL COMPANY (US) 2003-09-18 WO claimed
US-6485713-B1 CONTROLLING THE POLARITY OF A SOLVENT SYSTEM IN THE COMPOSITION TO CONTROL THE RATE OF PHOTODECAY OF A FILTER SYSTEM IN THE COMPOSITION THE C. P. HALL COMPANY 2002-11-26 US claimed
US-4584190-A AROMATIC, UNSATURATED, OXO, OXYESTER KAO CORPORATION (JP) 1986-04-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 ALDH1A1 205/4885KMT2A 2244/4885MEN1 3398/4885
US-20100047185-A1 ACTVIE SUBSTANCE COMBINATION UGT2B17, TACR2, UGT1A1 ALDH1A1 28/4885KMT2A 3114/4885MEN1 2776/4885
US-11993576-B2 N-benzyl-N-arylsulfonamide derivative and preparation and use thereof KCNB1, KCNB2, KCNA3 ALDH1A1 3085/4885KMT2A 808/4885MEN1 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.